VOYAGER THERAPEUTICS INC. - COMMON STOCK

Voyager Therapeutics Announces Third Quarter 2023 Conference Call and Webcast

30 10 2023 06:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics to Present at the Chardan Genetic Medicines Conference

25 9 2023 06:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

07 9 2023 15:01:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics to Participate in Upcoming Investor Conferences

30 8 2023 06:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

08 8 2023 15:01:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Appointment of Beth Shafer as Chief Business Officer

07 8 2023 07:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Reports Second Quarter 2023 Financial and Operating Results

03 8 2023 06:00:01 提供 Nasdaq GlobeNewswire

Voyager Therapeutics to Present at the Canaccord Genuity Growth Conference

02 8 2023 06:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Second Quarter 2023 Conference Call and Webcast

27 7 2023 06:00:01 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 7 2023 15:01:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Appointment of Jacquelyn Fahey Sandell as Chief Legal Officer

10 7 2023 07:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics to Present at the Jefferies Healthcare Conference

01 6 2023 06:00:01 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Presents Robust, Multi-Species Results from Preclinical Studies of IV-Delivered, TRACER™-Generated Novel Capsids at the ASGCT 26th Annual Meeting

18 5 2023 05:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Reports First Quarter 2023 Financial and Operating Results

09 5 2023 06:00:01 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Appointment of George Scangos, Ph.D., to Board of Directors

09 5 2023 05:55:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting

02 5 2023 15:30:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces First Quarter 2023 Conference Call and Webcast

02 5 2023 06:00:01 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Presents New Data Supporting Tau Antibody Program for Alzheimer’s Disease and GBA1 Gene Therapy Program for Parkinson’s Disease at the AD/PD™ Conference

28 3 2023 06:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

07 3 2023 06:00:01 提供 Nasdaq GlobeNewswire

Voyager Therapeutics to Receive $25 Million Payment for License of Next-Generation AAV Capsids for Multiple Neurologic Disease Targets

06 3 2023 06:00:00 提供 Nasdaq GlobeNewswire